Literature DB >> 7078875

Oral contraceptives and nonfatal vascular disease--recent experience.

J B Porter, J R Hunter, D A Danielson, H Jick, A Stergachis.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7078875

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  6 in total

Review 1.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

2.  Oral contraceptive estrogen content and adverse effects.

Authors:  M Russell; S Ramcharan
Journal:  Can Fam Physician       Date:  1987-02       Impact factor: 3.275

3.  [Pulmonary embolism with paradoxical coronary and peripheral arterial embolization. Increased risk of thrombosis caused by contraception with desogestrel and ethinylestradiol?].

Authors:  J Brockmeier; J Carlsson; S Miketic; R Meierhenrich; E Sorges; L Obergassel; U Tebbe
Journal:  Med Klin (Munich)       Date:  1997-01-15

4.  A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.

Authors:  R D Farmer; R A Lawrenson; J C Todd; T J Williams; K D MacRae; F Tyrer; G M Leydon
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

Review 5.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 6.  Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

Authors:  Rachel E J Roach; Frans M Helmerhorst; Willem M Lijfering; Theo Stijnen; Ale Algra; Olaf M Dekkers
Journal:  Cochrane Database Syst Rev       Date:  2015-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.